Market Tracker

10/23 2:53pm ET
37.67
BATS BZX Real-Time Price
As of 2:51pm ET
 -0.25 / -0.66%
Today’s Change
26.16
Today|||52-Week Range
46.81
+22.23%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close37.92
Today’s open37.88
Day’s range37.50 - 37.95
Volume7,068
Average volume (3 months)389,304
Market cap$1.6B
Dividend yield--
Data as of 2:51pm ET, 10/23/2017

Growth & Valuation

Earnings growth (last year)+21.43%
Earnings growth (this year)+34.47%
Earnings growth (next 5 years)+18.00%
Revenue growth (last year)+25.14%
P/E ratio73.8
Price/Sales10.05
Price/Book7.60

Competitors

 Today’s
change
Today’s
% change
IPXLImpax Laboratories I...-0.73-3.41%
ARRYArray Biopharma Inc-0.33-2.98%
LXRXLexicon Pharmaceutic...-0.21-1.88%
CBMCambrex Corp-0.60-1.14%
Data as of 2:51pm ET, 10/23/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)$0.11
Annual revenue (last year)$104.5M
Annual profit (last year)$11.7M
Net profit margin11.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts